RBC Europe’s Dynavax Technologies DVAX Stock Holding History

RBC Europe’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,390	Closed	-$142K	–	762
2021 Q3	$142K	Sell	7,390 -2,500	-25%	-$33.2K	0.01%	355
2021 Q2	$97.4K	Hold	9,890	–	–	﹤0.01%	439
2021 Q1	$97.2K	Hold	9,890	–	–	0.01%	410
2020 Q4	$44K	Hold	9,890	–	–	﹤0.01%	551
2020 Q3	$42.7K	Hold	9,890	–	–	﹤0.01%	493
2020 Q2	$87.7K	Hold	9,890	–	–	0.01%	352
2020 Q1	$34.9K	Hold	9,890	–	–	﹤0.01%	444
2019 Q4	$56.6K	Hold	9,890	–	–	0.01%	424
2019 Q3	$35.4K	Hold	9,890	–	–	﹤0.01%	513
2019 Q2	$39.5K	Hold	9,890	–	–	﹤0.01%	514
2019 Q1	$72.3K	Hold	9,890	–	–	0.01%	392
2018 Q4	$90.5K	Hold	9,890	–	–	0.01%	327
2018 Q3	$123K	Hold	9,890	–	–	0.01%	322
2018 Q2	$151K	Hold	9,890	–	–	0.02%	291
2018 Q1	$196K	Buy	9,890 +390	+4%	+$6.74K	0.02%	244
2017 Q4	$178K	Buy	9,500 +1,000	+12%	+$20.1K	0.02%	263
2017 Q3	$183K	Buy	+8,500	New	+$134K	0.02%	256

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RBC Europe's DVAX Position: Q4 2021 in Review

RBC Europe sold out of Dynavax Technologies (DVAX) in Q4 2021, closing a stake of 7,390 shares — an estimated $142K sold.

RBC Europe first reported a position in DVAX in Q3 2017 and held it in 17 quarters. The position peaked at $196K in Q1 2018. 200 funds tracked by Wall St. Rank hold DVAX as of Q4 2021.

RBC Europe reported no remaining Dynavax Technologies position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 7,390 Dynavax Technologies shares in Q4 2021, an estimated $142K.
RBC Europe first reported a position in Dynavax Technologies in Q3 2017 and held it in 17 quarters.
RBC Europe's Dynavax Technologies position peaked at $196K in Q1 2018.
200 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.